Clinical trial
A Phase 1, Single Ascending Dose, Double Blind, Placebo Controlled Study to Evaluate the Safety and Tolerability of Valproic Acid in Healthy Volunteers (Part 1) or Trauma Patients(Part 2)
NCT02872428 is registered in ClinicalTrials.gov with Dr. Hasan Alam as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1, Single Ascending Dose, Double Blind, Placebo Controlled Study to Evaluate the Safety and Tolerability of Valproic Acid in Healthy Volunteers (Part 1) or Trauma Patients(Part 2)
- Lead sponsor
- Dr. Hasan Alam
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- November 30, 2016
- Completion date
- September 29, 2017
- Enrollment
- 1 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
shock,hemorrhagic, trauma